Erik Nelson is a trained endocrinologist with specific expertise in nuclear receptor pharmacology. He has made significant contributions to the fields of reproductive physiology, pharmacology, bone biology and cancer biology. Breast cancer remains the most commonly...
John Katzenellenbogen directs a research program that intersects chemistry, biology, and medical applications with a particular focus on the action of estrogens in breast cancer and androgens in prostate cancer. He explores critical problems in hormone-regulated...
Benita Katzenellenbogen’s research in cancer, endocrinology, and women’s health has focused on nuclear receptors, mainly estrogen receptors, and their mechanical, physiological, and integrative actions, aiming to improve the effectiveness of endocrine therapies in...
Stephen Sligar has spent his professional career focused on the discovery, development, and use of chemical and biophysical tools to understand fundamental problems in biochemistry. Sligar’s lab developed the Nanodisc platform, which allows for the generation of a...
David Shapiro’s lab has spent over a decade studying estrogens, acting via estrogen receptor a (ERa), which plays a key role in most breast cancers. The Shapiro laboratory has leveraged its expertise in ERa action in cancer to identify new pathways of hormone action...
Jodi Flaws and her lab are interested in chemicals, such as pesticides and plasticizers, that affect female reproductive development and function and chemical exposures associated with adverse female menopausal outcomes. She has many years of experience studying the...
